Report Detail
Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Insights and Forecast to 2026
- RnM4132876 |
- 13 August, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Converting Enzyme (ACE) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented into
Sulfhydryl-containing Agents
Dicarboxylate-containing Agents
Phosphonate-containing Agents
Segment by Application, the Angiotensin Converting Enzyme (ACE) Inhibitors market is segmented into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
Regional and Country-level Analysis
The Angiotensin Converting Enzyme (ACE) Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Angiotensin Converting Enzyme (ACE) Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Angiotensin Converting Enzyme (ACE) Inhibitors Market Share Analysis
Angiotensin Converting Enzyme (ACE) Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiotensin Converting Enzyme (ACE) Inhibitors business, the date to enter into the Angiotensin Converting Enzyme (ACE) Inhibitors market, Angiotensin Converting Enzyme (ACE) Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
1 Study Coverage
- 1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Product Introduction
- 1.2 Market Segments
- 1.3 Key Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate by Type
- 1.4.2 Sulfhydryl-containing Agents
- 1.4.3 Dicarboxylate-containing Agents
- 1.4.4 Phosphonate-containing Agents
- 1.5 Market by Application
- 1.5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Growth Rate by Application
- 1.5.2 Hypertension
- 1.5.3 Cardiovascular Diseases
- 1.5.4 Kidney Diseases
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size, Estimates and Forecasts
- 2.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue 2015-2026
- 2.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales 2015-2026
- 2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Competitor Landscape by Players
- 3.1 Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturers
- 3.1.1 Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturers (2015-2020)
- 3.1.2 Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share by Manufacturers (2015-2020)
- 3.2 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturers
- 3.2.1 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturers (2015-2020)
- 3.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Angiotensin Converting Enzyme (ACE) Inhibitors Revenue in 2019
- 3.2.5 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price by Manufacturers
- 3.4 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturing Base Distribution, Product Types
- 3.4.1 Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
- 3.4.3 Date of International Manufacturers Enter into Angiotensin Converting Enzyme (ACE) Inhibitors Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Type (2015-2020)
- 4.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2015-2020)
- 4.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Type (2015-2020)
- 4.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Type (2021-2026)
- 4.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Type (2021-2026)
- 4.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Application (2015-2020)
- 5.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2015-2020)
- 5.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Application (2015-2020)
- 5.1.3 Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2015-2020)
- 5.2 Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Application (2021-2026)
- 5.2.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Angiotensin Converting Enzyme (ACE) Inhibitors Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors by Country
- 6.1.1 North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
- 6.1.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Type
- 6.3 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Application
7 Europe
- 7.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors by Country
- 7.1.1 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
- 7.1.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Type
- 7.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors by Region
- 8.1.1 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Region
- 8.1.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Type
- 8.3 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors by Country
- 9.1.1 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
- 9.1.2 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Type
- 9.3 Central & South America Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors by Country
- 10.1.1 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Country
- 10.1.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Type
- 10.3 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Facts & Figures by Application
11 Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Corporation Information
- 11.1.2 Abbott Laboratories Description and Business Overview
- 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.1.5 Abbott Laboratories Related Developments
- 11.2 Pfizer
- 11.2.1 Pfizer Corporation Information
- 11.2.2 Pfizer Description and Business Overview
- 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.2.5 Pfizer Related Developments
- 11.3 Novartis
- 11.3.1 Novartis Corporation Information
- 11.3.2 Novartis Description and Business Overview
- 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.3.5 Novartis Related Developments
- 11.4 Merck
- 11.4.1 Merck Corporation Information
- 11.4.2 Merck Description and Business Overview
- 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Merck Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.4.5 Merck Related Developments
- 11.5 Astra Zeneca
- 11.5.1 Astra Zeneca Corporation Information
- 11.5.2 Astra Zeneca Description and Business Overview
- 11.5.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.5.5 Astra Zeneca Related Developments
- 11.6 Jhonson and Johnson
- 11.6.1 Jhonson and Johnson Corporation Information
- 11.6.2 Jhonson and Johnson Description and Business Overview
- 11.6.3 Jhonson and Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.6.5 Jhonson and Johnson Related Developments
- 11.7 Eli Lilly
- 11.7.1 Eli Lilly Corporation Information
- 11.7.2 Eli Lilly Description and Business Overview
- 11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.7.5 Eli Lilly Related Developments
- 11.8 Sanofi
- 11.8.1 Sanofi Corporation Information
- 11.8.2 Sanofi Description and Business Overview
- 11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.8.5 Sanofi Related Developments
- 11.9 Bristol-Myers Squibb
- 11.9.1 Bristol-Myers Squibb Corporation Information
- 11.9.2 Bristol-Myers Squibb Description and Business Overview
- 11.9.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.9.5 Bristol-Myers Squibb Related Developments
- 11.10 Bayer
- 11.10.1 Bayer Corporation Information
- 11.10.2 Bayer Description and Business Overview
- 11.10.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.10.5 Bayer Related Developments
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Corporation Information
- 11.1.2 Abbott Laboratories Description and Business Overview
- 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Products Offered
- 11.1.5 Abbott Laboratories Related Developments
- 11.12 Teva Pharmaceutical
- 11.12.1 Teva Pharmaceutical Corporation Information
- 11.12.2 Teva Pharmaceutical Description and Business Overview
- 11.12.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Teva Pharmaceutical Products Offered
- 11.12.5 Teva Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Angiotensin Converting Enzyme (ACE) Inhibitors Market Estimates and Projections by Region
- 12.1.1 Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast by Regions 2021-2026
- 12.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast by Regions 2021-2026
- 12.2 North America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast (2021-2026)
- 12.2.1 North America: Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast (2021-2026)
- 12.2.2 North America: Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast (2021-2026)
- 12.2.3 North America: Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2021-2026)
- 12.3 Europe Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast (2021-2026)
- 12.3.1 Europe: Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast (2021-2026)
- 12.3.2 Europe: Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast (2021-2026)
- 12.3.3 Europe: Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast (2021-2026)
- 12.5.2 Latin America: Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Angiotensin Converting Enzyme (ACE) Inhibitors Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Angiotensin Converting Enzyme (ACE) Inhibitors Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Angiotensin Converting Enzyme (ACE) Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Angiotensin Converting Enzyme (ACE) Inhibitors Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Angiotensin Converting Enzyme (ACE) Inhibitors. Industry analysis & Market Report on Angiotensin Converting Enzyme (ACE) Inhibitors is a syndicated market report, published as Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Angiotensin Converting Enzyme (ACE) Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
